Poster Abstract Session:
057. HAI: Surveillance + Reporting
Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Investigative ID, Epidemiology and Infection Control, Adult ID

Return on Investment: How Infection Preventionists (IPs) Spend Their Time at an Academic Medical Center
Rachel Marrs, DNP, RN, CIC; Sylvia Garcia-Houchins, RN, MBA, CIC, FSHEA; Emily Landon, MD
The cost and mortality burden of hospital-onset antimicrobial resistant healthcare-associated infections in the United States
Richard E. Nelson, PhD; Marin Schweizer, PhD; Makoto Jones, MD, MS; Vanessa W. Stevens, PhD; Karim Khader, PhD; Eli Perencevich, MD, MS, FIDSA, FSHEA; Michael Rubin, MD, PhD, FIDSA; Matthew Samore, MD, FSHEA
Molecular epidemiology of carbapenem-resistant Enterobacter cloacae in a University Hospital in Japan.
Nobuyuki Tetsuka, M.D.; Mitsutaka Iguchi, M.D.; Hiroshi Morioka, M.D.; Yuka Tomita, M.D., Ph.D.; Tetsuya Yagi, M.D., Ph.D.
Antimicrobial Resistance and Attributable Burden of Pseudomonas aeruginosa in Hospitalized Patients
Dongmu Zhang, PhD; John Hawkshead III, DrPH; Sanjay Merchant, PhD
Use of the Extensively Drug Resistant Organism (XDRO) Registry for Carbapenem-Resistant Enterobacteriaceae (CRE) Reporting and Initiation of Transmission Precautions — Chicago, Illinois, 2016
Janna L. Kerins, VMD, MPH; Angela Tang, MPH; Stephanie Black, MD, MSc; Massimo Pacilli, MS MPH; Michael Y. Lin, MD, MPH; William E. Trick, MD; Sarah K. Kemble, MD
Antibiotic Resistance Increases with Local Temperature
Derek MacFadden, MD; Sarah McGough, MSc; David Fisman, MD; Mauricio Santillana, PhD; John Brownstein, PhD
Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the United States, 2011-2015
Uzma Ansari, MS; Adrian Lawsin, MS; Davina Campbell, MPH; Valerie Albrecht, MPH; Gillian McAllister, BS; Sandra Bulens, MPH; Maroya Spalding Walters, PhD, ScM; Jesse T. Jacob, MD; Sarah W. Satola, PhD; Lucy E. Wilson, MD, ScM; Ruth Lynfield, MD, FIDSA; Paula M Snippes Vagnone, MT (ASCP); Sarah J. Janelle, MPH, CIC; Karen Xavier, MT(ASCP); Ghinwa Dumyati, MD, FSHEA; Dwight Hardy, PhD; Erin C. Phipps, DVM, MPH; Karissa Culbreath, PhD; Zintars Beldavs, MS; Karim Morey, MS; Marion A. Kainer, MBBS, MPH; Sheri Roberts, MT; Alexander Kallen, MD, MPH; J. Kamile Rasheed, PhD; Maria S. Karlsson, PhD
  • IDWeekPoster_Ansari_Final1.pdf (598.5 kB)
  • 474
    2015 NHSN CAUTI Definition Change and its Impact on CLABSI Rates at an Academic Medical Center
    Sonali Advani, MD, MPH; Rachael Lee, MD; Mariann Schmitz, MPH, CIC; Martha Long, MSN, RN, CIC; Bernard Camins, MD, MSc
  • CAUTIposter-SA.pdf (585.0 kB)
  • 475
    Surveillance of hemodialysis events: A prospective multicenter study, first report from Turkey
    Imran Hasanoglu, MD, PhD; Rahmet Guner, Prof. Dr.; H. Veli Atalay, MD. PhD; Suzan Sahin, MD. PhD; Ergun Parmaksiz, MD. PhD; Fatma Yilmaz Karadag, MD. PhD; Sabahat Alışır Ecder, Assoc Prof.; Tugba Arslan Gulen, MD. PhD.; Zuhal Atan Ucar, MD. PhD; Oguz Karabay, Prof. Dr.; Savas Sipahi, Assoc. Prof.; Derya Yapar, MD. PhD.; Ibrahim Dogan, MD. PhD.; Irfan Baran, MD. PhD.; Esra Kaya Kilic, MD. PhD.; Murat Duranay, Assoc. Prof.; Gulden Ersoz, Prof. Dr.; Gulcan Turkmen, MD; A. Alper Kiykim, Prof. Dr.
  • poster-TRHIES.pdf (511.5 kB)
  • 476
    Introducing Hospital Onset Bloodstream Infection (HOBSI) as a Tool to Evaluate Infection Prevention: Assessment of 51 US Hospitals
    Mohamad Fakih, MD, MPH; Rebecca Battjes, MPH; Lisa Sturm, MPH; Lindsey Jones, BS; Clariecia Groves, MS; Angelo Bufalino, PhD; Ann Hendrich, PhD, RN; Ziad Haydar, MD, MBA
  • HOBSI Poster-final-no crops.pdf (228.6 kB)
  • 477
    Comparison of clinical characteristics and outcomes between community-acquired and healthcare-associated bacteremia cases due to Bacteroides species
    Naokatsu Ando, M.D; Kayoko Hayakawa, MD, PhD; Yuichi Katanami, MD; Kazuhisa Mezaki, MT; Saho Takaya, MD, MSc; Kei Yamamoto, M.D.; Nozomi Takeshita, M.D., Ph.D.; Satoshi Kutsuna, MD, PhD; Norio Ohmagari, MD, MSc, PhD
    Hospital Onset Staphylococcus aureus Bacteremia is a Better Measure than MRSA Bacteremia in Assessing Infection Prevention: Evaluation of 51 US Hospitals
    Mohamad Fakih, MD, MPH; Rebecca Battjes, MPH; Lisa Sturm, MPH; Lindsey Jones, BS; Clariecia Groves, MS; Angelo Bufalino, PhD; Ann Hendrich, PhD, RN
    Preventability of Hospital Onset Bacteremia and Fungemia: A Pilot Study of a Potential New Indicator of Healthcare-Associated Infections
    Raymund Dantes, MD, MPH; Clare Rock, MD MS; Aaron M. Milstone, MD, MHS, FIDSA, FSHEA; Jesse T. Jacob, MD; Sheri Chernetsky-Tejedor, MD; Anthony D. Harris, MD, MPH; Surbhi Leekha, MBBS, MPH
  • HOB poster submission pdf.pdf (130.7 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.